Schrödinger, Inc. (NASDAQ:SDGR - Get Free Report) was down 4.5% during mid-day trading on Tuesday . The company traded as low as $21.82 and last traded at $21.72. Approximately 87,582 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 745,702 shares. The stock had previously closed at $22.75.
Analysts Set New Price Targets
Several equities analysts have recently commented on SDGR shares. Piper Sandler lowered their target price on Schrödinger from $50.00 to $45.00 and set an "overweight" rating for the company in a report on Thursday, February 27th. KeyCorp upped their price objective on Schrödinger from $25.00 to $27.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Schrödinger presently has an average rating of "Buy" and a consensus target price of $32.29.
Read Our Latest Analysis on Schrödinger
Schrödinger Trading Down 1.5 %
The firm has a 50-day moving average of $23.11 and a 200 day moving average of $20.79. The stock has a market capitalization of $1.46 billion, a price-to-earnings ratio of -8.53 and a beta of 1.62.
Schrödinger (NASDAQ:SDGR - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The company reported ($0.55) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.20). The company had revenue of $88.32 million during the quarter, compared to analyst estimates of $83.20 million. Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. Equities research analysts predict that Schrödinger, Inc. will post -2.37 EPS for the current fiscal year.
Insider Activity at Schrödinger
In other news, CFO Geoffrey Craig Porges sold 5,491 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $21.76, for a total value of $119,484.16. Following the completion of the sale, the chief financial officer now owns 27,544 shares in the company, valued at $599,357.44. This represents a 16.62 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 8.60% of the company's stock.
Institutional Investors Weigh In On Schrödinger
Hedge funds and other institutional investors have recently bought and sold shares of the business. Avanza Fonder AB bought a new position in shares of Schrödinger during the 4th quarter valued at about $577,000. Barclays PLC lifted its stake in Schrödinger by 421.6% during the third quarter. Barclays PLC now owns 107,554 shares of the company's stock valued at $1,995,000 after purchasing an additional 86,933 shares during the last quarter. State Street Corp boosted its holdings in Schrödinger by 1.8% during the third quarter. State Street Corp now owns 2,155,620 shares of the company's stock worth $39,987,000 after buying an additional 38,972 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. grew its position in Schrödinger by 60.2% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,510,518 shares of the company's stock worth $67,718,000 after buying an additional 1,319,464 shares during the last quarter. Finally, Amundi lifted its position in shares of Schrödinger by 197.7% during the 4th quarter. Amundi now owns 26,753 shares of the company's stock valued at $544,000 after acquiring an additional 17,766 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.
About Schrödinger
(
Get Free Report)
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
See Also
Before you consider Schrödinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrödinger wasn't on the list.
While Schrödinger currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
